Literature DB >> 7470229

The problem of nonresponding estrogen receptor-positive patients with advanced breast cancer.

H Maass, W Jonat, G Stolzenbach, G Trams.   

Abstract

Patients with advanced breast cancer and low or poor concentration of estrogen receptors in tumor biopsies have little chance of responding to endocrine therapy. This problem was seen in a group of nonresponding estrogen receptor-positive (ER+) patients. Some comments on possible explanations for this phenomenon are made and suggestions to overcome it are given.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7470229     DOI： 10.1002/1097-0142(19801215)46:12+<2835::aid-cncr2820461420>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  13 in total

1.  Cell cycle expression of estrogen receptors determined by image analysis on human breast cancer cells in vitro and in vivo.

Authors:  P Rostagno; J L Moll; I Birtwisle-Peyrottes; F Ettore; C Caldani
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Influence of tissue heterogeneity on the determination of steroid receptors in breast cancer.

Authors:  H Geyer; M Eberl; B Hornberger
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

3.  Genomic DNA analysis of the estrogen receptor gene in breast cancer.

Authors:  F F Parl; D R Cavener; W D Dupont
Journal:  Breast Cancer Res Treat       Date:  1989-10       Impact factor: 4.872

4.  Cytochemistry of sex steroid receptors: a critique.

Authors:  K S McCarty; D S Reintgen; H F Seigler; K S McCarty
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

5.  Elevated insulin receptor content in human breast cancer.

Authors:  V Papa; V Pezzino; A Costantino; A Belfiore; D Giuffrida; L Frittitta; G B Vannelli; R Brand; I D Goldfine; R Vigneri
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

6.  Cell cycle expression of steroid receptors determined by image analysis on human breast cancer cell line: a hypothesis on the effects of antiestrogens.

Authors:  P Rostagno; C Caldani; B Lahlou
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  Quantification of cytochrome P-450-dependent cyclohexane hydroxylase activity in normal and neoplastic reproductive tissues.

Authors:  T I Senler; W L Dean; L F Murray; J L Wittliff
Journal:  Biochem J       Date:  1985-04-15       Impact factor: 3.857

Review 8.  Progestin regulation of insulin and insulin-like growth factor I receptors in cultured human breast cancer cells.

Authors:  I D Goldfine; V Papa; R Vigneri; P Siiteri; S Rosenthal
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

9.  Relevance of cell kinetics to hormonal response of receptor-positive advanced breast cancer.

Authors:  A Paradiso; V Lorusso; S Tommasi; F Schittulli; E Maiello; M De Lena
Journal:  Breast Cancer Res Treat       Date:  1988-04       Impact factor: 4.872

10.  The inhibitory effect of 4-chloro-2-(2,6-dichloro-4-hydroxyphenyl)-1-ethyl-6-hydroxyindole (D 15413) on estrogen-dependent mammary tumors.

Authors:  E von Angerer; J Prekajac; M R Schneider; M R Berger
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.